{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T17:39:21Z","timestamp":1782322761384,"version":"3.54.5"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s00259-023-06215-2","type":"journal-article","created":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T04:01:44Z","timestamp":1683000104000},"page":"2595-2604","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Results from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetry"],"prefix":"10.1007","volume":"50","author":[{"given":"Pablo M\u00ednguez","family":"Gabi\u00f1a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina Sj\u00f6green","family":"Gleisner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Cremonesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Stokke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Flux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cicone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Konijnenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Aldridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattias","family":"Sandstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Chiesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Paphiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eero","family":"Hippel\u00e4inen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Uribe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Solny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvano","family":"Gnesin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bernhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Chouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Fragoso","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Glatting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Verburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Gear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,2]]},"reference":[{"issue":"996","key":"6215_CR1","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1259\/bjr\/32706189","volume":"83","author":"MN Gaze","year":"2010","unstructured":"Gaze MN, Flux GD. Molecular radiotherapy \u2014 the radionuclide raffle? Br J Radiol. 2010;83(996):995\u20137.","journal-title":"Br J Radiol"},{"key":"6215_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3390\/ijms17010033","volume":"17","author":"SV Gudkov","year":"2016","unstructured":"Gudkov SV, Shilyagina NY, Vodeneev VA, Zvyagin AV. Targeted radionuclide therapy of human tumors. Int J Mol Sci. 2016;17:33.","journal-title":"Int J Mol Sci"},{"key":"6215_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40658-017-0194-3","volume":"4","author":"C Stokke","year":"2017","unstructured":"Stokke C, M\u00ednguezGabi\u00f1a P, Solny P, Cicone F, Sandstr\u00f6m M, Sj\u00f6greenGleisner K, et al. Dosimetry-based treatment planning for molecular radiotherapy: a summary of the 2017 report from the Internal Dosimetry Task Force. EJNMMI Phys. 2017;4:27.","journal-title":"EJNMMI Phys."},{"issue":"12","key":"6215_CR4","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1200\/JCO.2005.08.066","volume":"23","author":"DJ Kwekkeboom","year":"2005","unstructured":"Kwekkeboom DJ, Teunissen JJ, Bakker WH, de Herder WW, Feelders RA, et al. Radiolabeled somatostatin analog [177Lu-DOTA0, Tyr3] octreotate in patients with endocrine gastroenteropancreatic tumors. J Clin Oncol. 2005;23(12):2754\u201362.","journal-title":"J Clin Oncol"},{"issue":"2","key":"6215_CR5","first-page":"197","volume":"25","author":"JC Sisson","year":"1984","unstructured":"Sisson JC, Shapiro B, Beierwaltes WH, Glowniak JV, Nakajo M, Mangner TJ, et al. Radiopharmaceutical treatment of malignant pheochromocytoma. J Nucl Med. 1984;25(2):197\u2013206.","journal-title":"J Nucl Med"},{"key":"6215_CR6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1089\/thy.1997.7.163","volume":"7","author":"CT Sawin","year":"1997","unstructured":"Sawin CT, Becker DV. Radioiodine and the treatment of hyperthyroidism: the early history. Thyroid. 1997;7:163\u201376.","journal-title":"Thyroid"},{"key":"6215_CR7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1056\/NEJMoa1213755","volume":"369","author":"C Parker","year":"2013","unstructured":"Parker C, Nilsson S, Heinrich D, Helle SI, O\u2019Sullivan JM, Foss\u00e1 SD, et al. Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med. 2013;369:213\u201323.","journal-title":"N Engl J Med"},{"issue":"10","key":"6215_CR8","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1088\/0031-9155\/41\/10\/004","volume":"41","author":"J Zweit","year":"1996","unstructured":"Zweit J. Radionuclides and carrier molecules for therapy. Phys Med Biol. 1996;41(10):1905\u201314.","journal-title":"Phys Med Biol"},{"issue":"32","key":"6215_CR9","doi-asserted-by":"publisher","first-page":"5218","DOI":"10.2174\/1381612819666140110114902","volume":"20","author":"A Aerts","year":"2014","unstructured":"Aerts A, Impens MR, Gijs M, D\u2019Huyvetter M, Vanmarcke H, Ponsard B, et al. Biological carrier molecules of radiopharmaceuticals for molecular cancer imaging and targeted cancer therapy. Curr Pharm Des. 2014;20(32):5218\u201344.","journal-title":"Curr Pharm Des"},{"key":"6215_CR10","doi-asserted-by":"publisher","unstructured":"Umbricht CA, Benesova M, Schmid RM, Turler A, Schibli R, van der Meulen MP, et al. 44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617\u2014preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617. EJNMMI Res. 2017;7(1): https:\/\/doi.org\/10.1186\/s13550-017-0257-4","DOI":"10.1186\/s13550-017-0257-4"},{"key":"6215_CR11","doi-asserted-by":"publisher","unstructured":"Scarpa L, Buxbaum S, Kendler D, Fink K, Bektic J, Gruber L, et al. The 68Ga\/177Lu theragnostic concept in PSMA targeting of castration-resistant prostate cancer: correlation of SUVmax values and absorbed dose estimates. Eur J Nucl Med Mol Imaging. 2017;44(5): https:\/\/doi.org\/10.1007\/s00259-016-3609-9","DOI":"10.1007\/s00259-016-3609-9"},{"key":"6215_CR12","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.2967\/jnumed.116.178673","volume":"57","author":"C Kratochwil","year":"2016","unstructured":"Kratochwil C, Bruchertseifer F, Giesel FL, Weis M, Verburg FA, Mottaghy F, et al. 225Ac-PSMA-617 for PSMA-targeted a-radiation therapy of metastatic castration-resistant prostate Cancer. J Nucl Med. 2016;57:1941\u20134.","journal-title":"J Nucl Med"},{"key":"6215_CR13","volume-title":"Prescribing Recording and Reporting Photon Beam Therapy","author":"ICRU International Commission on Radiation Units and Measurements","year":"1993","unstructured":"ICRU International Commission on Radiation Units and Measurements. Prescribing Recording and Reporting Photon Beam Therapy. Bethesda, MD: ICRU Report 50; 1993."},{"key":"6215_CR14","volume-title":"Prescribing, recording and reporting photon beam therapy (Supplement to ICRU Report 50)","author":"ICRU International Commission on Radiation Units and Measurements","year":"1999","unstructured":"ICRU International Commission on Radiation Units and Measurements. Prescribing, recording and reporting photon beam therapy (Supplement to ICRU Report 50). Bethesda, MD: ICRU Report 50; 1999."},{"key":"6215_CR15","volume-title":"Prescribing, recording, and reporting electron beam therapy","author":"ICRU International Commission on Radiation Units and Measurements","year":"2004","unstructured":"ICRU International Commission on Radiation Units and Measurements. Prescribing, recording, and reporting electron beam therapy. Oxford: ICRU Report 71; 2004."},{"key":"6215_CR16","volume-title":"Prescribing, recording, and reporting proton-beam therapy","author":"ICRU International Commission on Radiation Units and Measurements","year":"2007","unstructured":"ICRU International Commission on Radiation Units and Measurements. Prescribing, recording, and reporting proton-beam therapy. Oxford: ICRU Report 78; 2007."},{"key":"6215_CR17","volume-title":"Prescribing, recording, and reporting photon-beam intensity modulated radiotherapy (IMRT)","author":"ICRU International Commission on Radiation Units and Measurements","year":"2010","unstructured":"ICRU International Commission on Radiation Units and Measurements. Prescribing, recording, and reporting photon-beam intensity modulated radiotherapy (IMRT). Oxford: ICRU Report 83; 2010."},{"key":"6215_CR18","volume-title":"Prescribing, recording, and reporting brachytherapy for cancer of the cervix","author":"ICRU International Commission on Radiation Units and Measurements","year":"2013","unstructured":"ICRU International Commission on Radiation Units and Measurements. Prescribing, recording, and reporting brachytherapy for cancer of the cervix. Oxford: ICRU Report 89; 2013."},{"key":"6215_CR19","volume-title":"Absorbed dose determination in external beam radiotherapy: an international code of practice for dosimetry based on absorbed dose to water","author":"International Atomic Energy Agency","year":"2000","unstructured":"International Atomic Energy Agency. Absorbed dose determination in external beam radiotherapy: an international code of practice for dosimetry based on absorbed dose to water. Vienna: IAEA TRS-398. IAEA; 2000."},{"key":"6215_CR20","volume-title":"Specification and acceptance testing of radiotherapy treatment planning systems","author":"International Atomic Energy Agency","year":"2007","unstructured":"International Atomic Energy Agency. Specification and acceptance testing of radiotherapy treatment planning systems. Vienna: IAEA TECDOC-1540. IAEA; 2007."},{"key":"6215_CR21","volume-title":"Commissioning and quality assurance of computerized planning systems for radiation","author":"International Atomic Energy Agency","year":"2004","unstructured":"International Atomic Energy Agency. Commissioning and quality assurance of computerized planning systems for radiation. IAEA TRS-: Treatment of Cancer, IAEA TRS-430. Vienna; 2004."},{"key":"6215_CR22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40658-017-0193-4","volume":"4","author":"K Sj\u00f6greenGleisner","year":"2017","unstructured":"Sj\u00f6greenGleisner K, Spezi E, Solny P, M\u00ednguezGabi\u00f1a P, Cicone F, Stokke C, et al. Variations in the practice of molecular radiotherapy and implementation of dosimetry: results from a European survey. EJNMMI Phys. 2017;4:28.","journal-title":"EJNMMI Phys."},{"key":"6215_CR23","unstructured":"Council of the European Union. European Council Directive 2013\/59\/Euratom on basic safety standards for protection against the dangers arising from exposure to ionising radiation and repealing Directives 89\/618\/Euratom, 90\/641\/Euratom, 96\/29\/Euratom, 97\/43\/Euratom and 2003\/122\/Euratom. Official Journal of the EU. 2014;L13:1\u201373."},{"key":"6215_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-020-05038-9","author":"M Konijnenberg","year":"2020","unstructured":"Konijnenberg M, Herrmann K, Kobe C, Verburg E, Hinforf C, Hustinx R, Lassmann M. EANM position paper on article 56 of the Council Directive 2013\/59\/Euratom (basic safety standards) for nuclear medicine therapy. Eur J Nucl Med Mol Imaging. 2020. https:\/\/doi.org\/10.1007\/s00259-020-05038-9.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6215_CR25","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/abc707","volume":"65","author":"AJ Craig","year":"2020","unstructured":"Craig AJ, Rojas B, Wevrett JL, Hamer H, Fenwick A, Gregory R. IPEM topical report: current molecular radiotherapy service provision and guidance on the implications of setting up a dosimetry service. Phys Med Biol. 2020;65: 245038.","journal-title":"Phys Med Biol"},{"key":"6215_CR26","volume-title":"Nuclear Medicine Resources Manual","author":"International Atomic Energy Agency","year":"2006","unstructured":"International Atomic Energy Agency. Nuclear Medicine Resources Manual. Vienna: IAEA; 2006."},{"key":"6215_CR27","volume-title":"Medical physics staffing needs in diagnostic imaging and radionuclide therapy: an activity based approach","author":"International Atomic Energy Agency","year":"2018","unstructured":"International Atomic Energy Agency. Medical physics staffing needs in diagnostic imaging and radionuclide therapy: an activity based approach. Vienna: Human Health Reports No. 15 IAEA; 2018."},{"key":"6215_CR28","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.ejmp.2016.03.001","volume":"32","author":"S Evans","year":"2016","unstructured":"Evans S, Christofides S, Brambilla M. The European Federation of Organisations for Medical Physics. Policy Statement No. 7.1: The roles, responsibilities and status of the medical physicist including the criteria for the staffing levels in a Medical Physics. Phys Med. 2016;32:533\u201340.","journal-title":"Phys Med"},{"key":"6215_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40658-020-0282-7","volume":"7","author":"J Gear","year":"2020","unstructured":"Gear J, Chiesa C, Lassmann M, M\u00ednguezGabi\u00f1a P, Tran-Gia J, Stokke C, Flux G. EANM Dosimetry Committee series on standard operational procedures for internal dosimetry for 131I mIBG treatment of neuroendocrine tumours. EJNMMI Phys. 2020;7:15.","journal-title":"EJNMMI Phys."},{"key":"6215_CR30","doi-asserted-by":"publisher","first-page":"4197","DOI":"10.1118\/1.3190392","volume":"36","author":"EE Klein","year":"2009","unstructured":"Klein EE, Hanley J, Bayouth J, Yin F, Simon W, Dresser S, et al. Task Group 142 report: quality assurance of medical accelerators. Med Phys. 2009;36:4197\u2013212.","journal-title":"Med Phys"},{"key":"6215_CR31","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.1118\/1.2959723","volume":"35","author":"WM Butler","year":"2008","unstructured":"Butler WM, Bice WS, DeWerd LA, Hevezi JM, SaifulHuq M, Ibbott GS, et al. Third-party brachytherapy source calibrations and physicist responsibilities: report of the AAPM Low Energy Brachytherapy Source Calibration Working Group. Med Phys. 2008;35:3860\u20135.","journal-title":"Med Phys"},{"key":"6215_CR32","unstructured":"Aletti P, et al. Recommendations for a quality assurance programme in external radiotherapy, ESTRO, Booklet No.2, 1995"},{"key":"6215_CR33","doi-asserted-by":"publisher","unstructured":"Klein EE, Hanley J, Bayouth J, Yin F-F, Simon W, Dresser S, Serago C, Aguirre F, Ma L, Arjomandy B, Liu C, Sandin C, Holmes T. Task Group 142 report: Quality assurance of medical acceleratorsa). Med Phys. 2009;36:4197\u2013212. https:\/\/doi.org\/10.1118\/1.3190392","DOI":"10.1118\/1.3190392"},{"key":"6215_CR34","doi-asserted-by":"publisher","unstructured":"Lassmann M, H\u00e4nscheid H, Chiesa C, Hindorf C, Flux G, Luster M; EANM Dosimetry Committee.\u00a0EANM Dosimetry\u00a0Committee\u00a0series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy. Eur J Nucl Med Mol Imaging. 2008;35(7):1405\u201312. https:\/\/doi.org\/10.1007\/s00259-008-0761-x","DOI":"10.1007\/s00259-008-0761-x"},{"issue":"6","key":"6215_CR35","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1007\/s00259-010-1422-4","volume":"37","author":"C Hindorf","year":"2010","unstructured":"Hindorf C, Glatting G, Chiesa C, Linden O, Flux G. EANM Dosimetry Committee guidelines for bone marrow and whole-body dosimetry. Eur J Nucl Med Mol Imaging. 2010;37(6):1238\u201350.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"6215_CR36","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1007\/s00259-013-2387-x","volume":"40","author":"H H\u00e4nscheid","year":"2013","unstructured":"H\u00e4nscheid H, Canzi C, Eschner W, Flux G, Luster M, Strigari L, Lassmann M. EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry II. Dosimetry prior to radioiodine therapy of benign thyroid diseases. Eur J Nucl Med Mol Imaging. 2013;40(7):1126\u201334.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"6215_CR37","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.2967\/jnumed.111.100123","volume":"53","author":"YK Dewaraja","year":"2012","unstructured":"Dewaraja YK, Frey EC, Sgouros G, Brill AB, Roberson P, Zanzonico PB, Ljungberg M. MIRD Pamphlet No. 23: Quantitative SPECT for patient-specific 3-dimensional dosimetry in internal radionuclide therapy. J Nucl Med. 2012;53(8):1310\u201325.","journal-title":"J Nucl Med"},{"issue":"12","key":"6215_CR38","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.2967\/jnumed.113.122390","volume":"54","author":"YK Dewaraja","year":"2013","unstructured":"Dewaraja YK, Ljungberg M, Green AJ, Zanzonico PB, Frey EC. MIRD Pamphlet No. 24: Guidelines for quantitative 131I SPECT in dosimetry applications. J Nucl Med. 2013;54(12):2182\u20138.","journal-title":"J Nucl Med"},{"issue":"1","key":"6215_CR39","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2967\/jnumed.115.159012","volume":"57","author":"M Ljungberg","year":"2016","unstructured":"Ljungberg M, Celler A, Konijnenberg MW, Eckerman KF, Dewaraja YK, Sj\u00f6green-Gleisner K. MIRD Pamphlet No. 26: Joint EANM\/MIRD guidelines for quantitative 177Lu SPECT applied for dosimetry of radiopharmaceutical therapy. J Nucl Med. 2016;57(1):151\u201362.","journal-title":"J Nucl Med"},{"key":"6215_CR40","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2967\/jnumed.117.193706","volume":"59","author":"H H\u00e4nscheid","year":"2018","unstructured":"H\u00e4nscheid H, Lapa C, Buck AK, Lassmann M, Werner RA. Dose mapping after endoradiotherapy with 177Lu-DOTATATE\/DOTATOC by a single measurement after 4 days. J Nucl Med. 2018;59:75\u201381.","journal-title":"J Nucl Med"},{"key":"6215_CR41","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1007\/s00259-018-4136-7","volume":"45","author":"JI Gear","year":"2018","unstructured":"Gear JI, Cox MG, Gustafsson J, Sj\u00f6greenGleisner K, Murray I, Glatting G, et al. EANM practical guidance on uncertainty analysis for molecular radiotherapy absorbed dose calculations. Eur J Nucl Med Mol Imaging. 2018;45:2456\u201374.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"6215_CR42","first-page":"37S","volume":"40","author":"JA Siegel","year":"1999","unstructured":"Siegel JA, Thomas SR, Stubbs JB, Stabin MG, Hays MT, Koral KF, et al. MIRD Pamphlet No. 16: techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. J Nucl Med. 1999;40(2):37S-61S.","journal-title":"J Nucl Med"},{"key":"6215_CR43","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1007\/s00259-009-1347-y","volume":"37","author":"E BusemannSokole","year":"2010","unstructured":"BusemannSokole E, Plachcinska A, Brittenn A. Routine quality control recommendations for nuclear medicine instrumentation. Eur J Nucl Med Mol Imaging. 2010;37:662\u201371.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"6215_CR44","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.2967\/jnumed.107.050203","volume":"49","author":"P Zanzonico","year":"2008","unstructured":"Zanzonico P. Routine quality control of clinical nuclear medicine instrumentation: a brief review. J Nucl Med. 2008;49(7):1114\u201331.","journal-title":"J Nucl Med"},{"issue":"1","key":"6215_CR45","first-page":"92","volume":"20","author":"K Sj\u00f6greenGleisner","year":"2005","unstructured":"Sj\u00f6greenGleisner K, Ljunberg M, Wingardh K, Minarik D, Strand SE. The LundADose method for planar image activity quantification and absorbed-dose assessment in radionuclide therapy. Cancer Biother Radiopharm. 2005;20(1):92\u20137.","journal-title":"Cancer Biother Radiopharm"},{"issue":"7","key":"6215_CR46","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1118\/1.1945348","volume":"32","author":"G Glatting","year":"2005","unstructured":"Glatting G, Landmann M, Kull T, Wunderlich A, Blumstein NM, Buck AK, et al. Internal radionuclide therapy: the ULMDOS software for treatment planning. Med Phys. 2005;32(7):2399\u2013405.","journal-title":"Med Phys"},{"issue":"6","key":"6215_CR47","first-page":"1023","volume":"46","author":"MG Stabin","year":"2005","unstructured":"Stabin MG, Sparks RB, Crowe E. OLINDA\/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 2005;46(6):1023\u20137.","journal-title":"J Nucl Med"},{"issue":"3","key":"6215_CR48","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.zemedi.2015.01.001","volume":"25","author":"P Kletting","year":"2015","unstructured":"Kletting P, Schimmel S, H\u00e4nscheid H, Luster M, Fernandez M, Nosske D, et al. The NUKDOS software for treatment planning in molecular radiotherapy. Z Med Phys. 2015;25(3):264\u201374.","journal-title":"Z Med Phys"},{"issue":"5","key":"6215_CR49","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/MNM.0000000000000662","volume":"38","author":"ET Hippelainen","year":"2017","unstructured":"Hippelainen ET, Tenhunen MJ, Maenpaa HO, Heikkonen JJ, Sohlberg AO. Dosimetry software Hermes Internal Radiation Dosimetry: from quantitative image reconstruction to voxel-level absorbed dose distribution. Nucl Med Commun. 2017;38(5):357\u201365.","journal-title":"Nucl Med Commun"},{"issue":"1","key":"6215_CR50","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13550-017-0339-3","volume":"7","author":"M Andersson","year":"2017","unstructured":"Andersson M, Johansson L, Eckerman K, Mattsson S. IDAC-Dose 2.1, an internal dosimetry program for diagnostic nuclear medicine based on the ICRP adult reference voxel phantoms. EJNMMI Res. 2017;7(1):88.","journal-title":"EJNMMI Res"},{"issue":"1","key":"6215_CR51","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ejmp.2018.09.073","volume":"56","author":"E Mora-Ramirez","year":"2018","unstructured":"Mora-Ramirez E, Cassol E, Santoro L, Chouaf E, Trauchessec D, Pouget J, et al. 60 Comparison of organ-based absorbed doses estimations by using PLANET\u00aeDose and OLINDA\/EXM V2.0 in patients with peptide receptor radionuclide therapy (PRRT) treated with Lutathera\u00ae. Phys Med. 2018;56(1):34.","journal-title":"Phys Med"},{"issue":"5","key":"6215_CR52","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1002\/mp.13444","volume":"46","author":"NM Maughan","year":"2019","unstructured":"Maughan NM, Garcia-Ramirez J, Arpidone M, Swallen A, Laforest R, Goddu SM, et al. Validation of post-treatment PET-based dosimetry software for hepatic radioembolization of Yttrium-90 microspheres. Med Phys. 2019;46(5):2394\u2013402.","journal-title":"Med Phys"},{"key":"6215_CR53","doi-asserted-by":"publisher","unstructured":"Chauvin M, Borys D, Botta F, Bzowski P, Dabin J, Denis-Bacelar AM, et al. OpenDose: open access resources for nuclear medicine dosimetry. J Nucl Med. 2020; pii: jnumed.119.240366. https:\/\/doi.org\/10.2967\/jnumed.119.240366","DOI":"10.2967\/jnumed.119.240366"},{"key":"6215_CR54","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3389\/fonc.2018.00215","volume":"8","author":"P Jackson","year":"2018","unstructured":"Jackson P, Hardcastle N, Dawe N, Kron T, Hofman MS, Hicks RJ. Deep learning renal segmentation for fully automated radiation dose estimation in unsealed source therapy. Front Oncol. 2018;8:215.","journal-title":"Front Oncol"},{"issue":"2","key":"6215_CR55","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.radonc.2014.08.029","volume":"112","author":"C Grau","year":"2014","unstructured":"Grau C, Defourny N, Malicki J, Dunscombe P, Borras JM, Coffey M, et al. Radiotherapy equipment and departments in the European countries: final results from the ESTRO-HERO survey. Radiother Oncol. 2014;112(2):155\u201364.","journal-title":"Radiother Oncol"},{"issue":"2","key":"6215_CR56","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.radonc.2014.08.034","volume":"112","author":"Y Lievens","year":"2014","unstructured":"Lievens Y, Defourny N, Coffey M, Borras JM, Dunscombe P, Slotman B, et al. Radiotherapy staffing in the European countries: final results from the ESTRO-HERO survey. Radiother Oncol. 2014;112(2):178\u201386.","journal-title":"Radiother Oncol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06215-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-023-06215-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06215-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T21:02:38Z","timestamp":1688418158000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-023-06215-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,2]]},"references-count":56,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["6215"],"URL":"https:\/\/doi.org\/10.1007\/s00259-023-06215-2","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,2]]},"assertion":[{"value":"2 May 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This manuscript does not contain proprietary research involving either humans or animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This manuscript does not contain proprietary human data; accordingly, an informed consent is not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}